Tag: tregs

[Biolojic in Business Wire] First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s Phase 1/2 Clinical Trial for AU-007, a Computationally Designed IL-2...

Crowdfunding January 25, 2024

LARKSPUR, Calif.–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of best-in-class IL-2 therapeutics, today announced dosing of the...

Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice – Nature Communications

Biotechnology September 1, 2023

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Biotechnology June 7, 2023

No posts to display

Latest Intelligence

Generative Data Intelligence

Tag: tregs

[Biolojic in Business Wire] First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s Phase 1/2 Clinical Trial for AU-007, a Computationally Designed IL-2...

Top News

Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice – Nature Communications

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Latest Intelligence